Ascendis Pharma A (ASND) Inventory (2021 - 2025)

Ascendis Pharma A has disclosed Inventory across 5 years of filings, most recently posting $351.0 million for Q4 2025.

• Inventory for Q4 2025 came in at $351.0 million, up 11.12% year-over-year; the trailing twelve-month figure through Dec 2025 was $351.0 million (up 11.12% YoY), and the FY2025 annual result was $351.0 million, up 11.12% from the prior year.
• Inventory came in at $351.0 million for Q4 2025 at Ascendis Pharma A, up from $315.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $351.0 million in Q4 2025 to a low of $86.3 million in Q4 2021.
• The 5-year median for Inventory is $224.8 million (2023), against an average of $222.3 million.
• Across the five-year window, Inventory soared 68.62% in 2023 and gained 11.12% in 2025, its largest moves.
• Ascendis Pharma A's Inventory stood at $86.3 million in 2021, then soared by 54.55% to $133.3 million in 2022, then jumped by 68.62% to $224.8 million in 2023, then jumped by 40.52% to $315.9 million in 2024, then climbed by 11.12% to $351.0 million in 2025.
• The last three Inventory figures came in at $351.0 million (Q4 2025), $315.9 million (Q4 2024), and $224.8 million (Q4 2023), per Business Quant data.